pathogens Article West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 Serena Marchi 1,* , Emanuele Montomoli 1,2 , Simonetta Viviani 1 , Simone Giannecchini 3 , Maria A. Stincarelli 3 , Gianvito Lanave 4, Michele Camero 4, Caterina Alessio 1, Rosa Coluccio 1,2 and Claudia Maria Trombetta 1 1 Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy;
[email protected] (E.M.);
[email protected] (S.V.);
[email protected] (C.A.);
[email protected] (R.C.);
[email protected] (C.M.T.) 2 VisMederi S.r.l., 53100 Siena, Italy 3 Department of Experimental and Clinical Medicine, University of Florence, 50134 Firenze, Italy; simone.giannecchini@unifi.it (S.G.);
[email protected] (M.A.S.) 4 Department of Veterinary Medicine, University of Bari, 70010 Valenzano, Italy;
[email protected] (G.L.);
[email protected] (M.C.) * Correspondence:
[email protected] Abstract: Although in humans West Nile virus is mainly the cause of mild or sub-clinical infections, in some cases a neuroinvasive disease may occur predominantly in the elderly. In Italy, several cases of West Nile virus infection are reported every year. Tuscany was the first Italian region where the virus was identified; however, to date only two cases of infection have been reported in humans. This study aimed at evaluating the prevalence of antibodies against West Nile virus in the area of Siena Citation: Marchi, S.; Montomoli, E.; Province to estimate the recent circulation of the virus. Human serum samples collected in Siena Viviani, S.; Giannecchini, S.; between 2016 and 2019 were tested for the presence of antibodies against West Nile virus by ELISA.